trending Market Intelligence /marketintelligence/en/news-insights/trending/UXJgAZBkA2f05TOVNfLmSA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Acasti Pharma falls out of compliance with Nasdaq listing requirement

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Acasti Pharma falls out of compliance with Nasdaq listing requirement

Canada's Acasti Pharma Inc. said it was no longer in compliance with Nasdaq's $1 minimum bid price listing requirement.

The drugmaker has until June 24, with a possibly of extension, to regain compliance.

The development has no immediate effect on Acasti's listing. The company said it will evaluate all available options to resolve the deficiency.